Clin Shoulder Elb Search

CLOSE


Clin Shoulder Elb > Volume 28(1); 2025 > Article
Park and Park: Effectiveness of a combined arthroscopic and antibiotic-impregnated bead approach for septic shoulder arthritis management: a case series

Abstract

Background

This study sought to evaluate the effectiveness of a combined treatment approach for septic shoulder arthritis involving arthroscopic synovectomy and use of antibiotic-impregnated polymethylmethacrylate (PMMA) beads for localized antibiotic delivery.

Methods

This retrospective study included 22 patients with septic shoulder arthritis treated at our institution between 2017 and 2023. The treatment involved arthroscopic lavage, debridement, and insertion of antibiotic-impregnated PMMA beads. Patients were evaluated preoperatively and postoperatively based on laboratory tests, imaging, joint fluid analysis, and physical examination. Treatment efficacy was assessed based on normalization of C-reactive protein (CRP) levels, pain reduction as measured using a visual analog scale (VAS), and improvement in shoulder function according to Constant-Murley score.

Results

All 22 patients demonstrated successful resolution of infection, with only one case of recurrence, leading to a notably low recurrence rate of 5%. Recurrence was determined based on clinical signs (aggravated pain, swelling, and fever) and laboratory markers (elevated CRP and white blood cell count). Mean follow-up duration was 20.2 months. Significant reductions in pain (average VAS score reduction from 8.1 to 2.4, P<0.001) were observed, and mean Constant-Murley score at final follow-up was 60.7, reflecting improved shoulder function.

Conclusions

Arthroscopic debridement combined with localized antibiotic delivery using PMMA beads is an effective and safe treatment for septic shoulder arthritis. This method offers substantial advantages over traditional treatments, as evidenced by the very low recurrence rate.

Level of evidence

IV.

INTRODUCTION

Orthopedic infections, which can compromise surgical outcomes, often require long-term antibiotic therapy. The incidence of bacterial joint infection is reported to be 4 to 10 out of 100,000 per year, and the third most prevalent site is the native shoulder joint, followed by the hip and knee [1]. Conventional treatment involves early drainage of the joint along with intravenous antibiotic administration [2]. However, the best method for joint decompression remains controversial, as various techniques have yielded satisfactory results [3].
Arthroscopy is preferred because of its effectiveness in decompressing infected joints, particularly in the knee, with minimal residual complications [4]. The use of arthroscopy for managing septic shoulder arthritis has increased owing to the advantages of the technique over open procedures, such as small incisions, less postoperative pain, posterior joint visualization, and generally positive clinical outcomes [5,6]. However, the rate of reoperation after arthroscopic management is notably high at 26% to 32% [7,8]. This underscores the need for improved treatment strategies that effectively combat infection while reducing the likelihood of recurrence and subsequent surgeries [8].
Our treatment protocol for septic shoulder arthritis is arthroscopic synovectomy followed by strategic placement of antibiotic-impregnated polymethylmethacrylate (PMMA) beads in the subacromial space. This technique provides localized antibiotic delivery directly to the site of infection, enhancing treatment efficacy and potentially reducing the need for further surgery. In this study, we retrospectively reviewed the outcomes of 22 patients with septic shoulder arthritis who were treated using this method. We evaluated the effectiveness of antibiotic-laden PMMA beads for treating infectious arthritis in the shoulder joint and assessed the impact of this approach on the rate of reoperation.

METHODS

This study was approved by the Institutional Review Board of Yeungnam University Hospital (No. YUMC 2024-03-061). The informed consent for this retrospective study was waived.

Patients

Data for patients diagnosed with septic shoulder arthritis who underwent arthroscopic lavage and debridement combined with systemic antibiotic treatment based on bacterial sensitivity results at our institution between 2017 and 2023 were retrospectively analyzed. The exclusion criteria were age of <15 years, tuberculosis, and clear osteomyelitis findings on preoperative magnetic resonance imaging (MRI).
A total of 22 patients (11 men and 11 women) were included in the study, with a mean age of 67.7 years (range, 44–84 years) at the time of surgery. The average symptom duration before admission to our institution was 13.1 days (range, 2–90 days). Regarding infections, 12 patients developed infections after injections, 8 had primary infections, and 2 had infections following rotator cuff tear (RCT) repair. Regarding shoulder issues, 11 patients reported problems in their right shoulder, and the remaining 11 had issues in their left shoulder. Initial assessments involved comprehensive medical histories and physical examinations. For comorbidities, four patients had diabetes, three had cardiovascular diseases, and two had both. Three patients initially underwent arthroscopic synovectomy for septic shoulder arthritis at a different hospital but were then transferred to our institution because of inadequate management of their condition. Moreover, one patient presented with both septic shoulder and knee arthritis and simultaneously underwent arthroscopic synovectomy for both the affected areas.
All patients underwent simple radiography (anteroposterior and axial) and MRI. Laboratory tests included white blood cell (WBC) count, erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP) level. Joint fluid was aspirated in all the patients preoperatively. Septic shoulder arthritis was diagnosed preoperatively based on the following criteria: (1) clinical manifestations including joint swelling, pain, and local warmth; (2) laboratory evidence of elevated WBC count (>10,000 cells/mL), ESR (>10 mm/hr), and CRP level (>0.5 mg/dL) [9]; (3) enhanced MRI findings of septic arthritis such as joint effusion, abscess, synovial thickening, and periarticular soft-tissue edema [10]; and (4) aspirated joint fluid with a WBC count of >50,000 cells/mL [2]. Septic arthritis was postoperatively confirmed based on the following criteria: (1) intraoperative arthroscopic findings of septic arthritis established by Stutz et al. [11] and (2) a positive culture result of the joint fluid or by histopathologic examination. Postoperative recurrent infection was confirmed based on the following criteria: (1) recurrent clinical manifestations including aggravated pain and fever; (2) rebounding laboratory evidence, including elevated WBC count, ESR, and CRP level; and (3) aspirated joint fluid suggestive of recurrent infection with a WBC count of >50,000 cells/mL [2,7,12].
Preoperative and postoperative evaluations were continuous. Observations included physical changes such as fever as well as monitoring WBC count, ESR, and CRP levels to assess the effectiveness of treatment for septic arthritis. Successful treatment was defined as the normalization of CRP levels. Functional outcomes were evaluated using the Constant-Murley score and a 10-point visual analog scale (VAS) for pain, with 0 indicating no pain and 10 indicating severe pain. All cases were classified according to the Gächter staging system, based on intraoperative findings [11].

Operative Technique

Confirmation of septic arthritis indicates immediate surgery. At our institution, arthroscopic shoulder surgery is performed under general anesthesia with patients in the lateral position. Before expanding the shoulder joint with saline, joint fluid was aspirated for culture and WBC count. For the initial examination of the shoulder joint, a 4-mm 30° arthroscope was inserted through the posterior portal. An anterior portal was established for instrumentation. Frozen and permanent biopsies were performed to confirm synovitis. The joint was lavaged using a 5.5-mm inflow cannula, and fibrous debris and inflamed synovial tissues were removed using a 4.2-mm powered shaver. The subacromial space was inspected through the posterior, lateral, and anterosuperior portals, with subsequent removal of inflamed synovial tissue. Irrigation was performed using 20 to 30 L of saline. Subsequently, 1,000 mg of vancomycin was mixed with 20 g of gentamicin mixed PMMA to create antibiotic-loaded cement beads on surgical wire (Fig. 1). Typically, seven beads were formed into long narrow strips and then linked together in a chain shape. After the cement had completely solidified, the beads were placed in the subacromial space during arthroscopy using a large inflow cannula (Fig. 2). A closed suction drain was inserted at the end of surgery (Fig. 3).
The initial intravenous antibiotic was cefazolin. According to the results of culture and biopsy, antibiotic therapy was adopted after consultation with the Infectious Disease Department. In cases where patients had previously received antibiotics at other hospitals, experienced recurrence, or developed allergic reactions, the antibiotic regimen was adjusted accordingly in consultation with the Infectious Disease Department. Intravenous antibiotic therapy was continued for an average of 4.3 weeks (range, 1–10 weeks) until CRP levels normalized. Subsequently, oral antibiotics were administered to ensure a minimum treatment duration of 6 weeks [13-15].
Approximately 4.6 weeks (range, 3–8 weeks) later, we removed antibiotic-loaded cement beads when the CRP levels normalized. In patients with chronic conditions such as chronic kidney disease or chronic obstructive pulmonary disease, CRP levels may not normalize; hence, the beads were removed once CRP levels decreased significantly compared to baseline and when no clinical symptoms such as shoulder pain or redness were observed. If the patient’s condition permitted, diagnostic arthroscopy was performed after bead removal to confirm whether osteomyelitis was present at the rotator cuff insertion site of the greater tuberosity and whether purulent synovitis remained. If osteomyelitis was observed near the greater tuberosity during diagnostic arthroscopy, curettage and biopsy were performed [16]. Subsequently, drains were removed 1 to 2 days postoperatively, and no more antibiotics were administered (Fig. 4).

RESULTS

In this study, we analyzed 22 patients who underwent a combined treatment approach for septic shoulder arthritis involving arthroscopic synovectomy and use of antibiotic-impregnated PMMA beads. Demographic characteristics and preoperative evaluation findings are summarized in Table 1. Laboratory analyses revealed an average CRP level of 10.3 mg/dL (range, 0.73–23.70 mg/dL) and ESR of 52.8 mm/hr (range, 12–120 mm/hr). Mean WBC count in the preoperatively aspirated joint fluid was 66,873/µL (range, 2,675–240,000/µL). Regarding infection severity, the distribution of Gächter stages was as follows: stage I, 1 shoulder (5%); stage II, 11 shoulders (50%); stage III, 6 shoulders (27%); and stage IV, 4 shoulders (18%) (Table 2). Moreover, MRI of all 22 shoulder joints revealed joint effusion. Important demographic data for the study group are listed in Table 3.
Among the 22 patients, none showed symptoms of shoulder pain or redness before bead removal. CRP levels either normalized or significantly decreased and remained stable in all patients within an average of 3.4 weeks (range, 1–11 weeks) after the initial surgery. Consequently, beads were removed from all patients. Following bead removal, 21 patients remained recurrence-free. One patient exhibited signs of recurrence, including elevated CRP level 4 months later. This patient was infected with Candida species and had a Gächter stage IV infection. Open surgical debridement was performed, and no signs of infection were observed thereafter.
One patient experienced an infection at the site where the Hemovac was removed, which required open exploration and bead removal after the initial surgery. The infection was successfully managed after a second surgery. Another patient had osteomyelitis in the greater tuberosity of the humerus during diagnostic arthroscopy performed after bead removal. Consequently, curettage was performed using an arthroscope, thus controlling the infection. One patient underwent RCT repair after successful infection management; however, subsequent follow-up revealed re-rupture in this patient.
The causative organism was identified in 10 patients, with Staphylococcus aureus being the most common (isolated from seven patients). Methicillin-resistant Staphylococcus aureus (MRSA) was identified in one patient, resulting in an MRSA prevalence rate of 10% among culture-positive cases. The other two patients were infected with Streptococcus, and one patient was infected with Candida species (Table 4). Histopathological analysis of surgical biopsy specimens from the synovial tissues of all patients revealed acute active inflammation consistent with septic arthritis.
Except for one patient who experienced recurrence during initial follow-up, no further infections were observed. All patients eventually had well-healed wounds without reinfection until final follow-up. The average follow-up period was 20.2 months (range, 6–51 months). All patients experienced pain preoperatively, with an average pain level of 8.1 on the VAS (range, 3–10). At the time of follow-up, the average pain level had improved to 2.4 (range, 0–8). The average Constant-Murley score for functional outcomes at the final follow-up was 60.7 points (range, 17–81 points).

DISCUSSION

Although septic arthritis of the shoulder is less prevalent than that of the knee or hip joints, it poses significant management challenges and can result in considerable morbidity among affected patients [5]. Various treatment options include serial aspiration, open arthrotomy with irrigation and drainage, and arthroscopic irrigation and drainage, all of which have limitations. The infection recurrence rate following arthroscopic surgery for septic shoulder arthritis was approximately 30% [8].
Surgical treatment for septic arthritis aims to remove as much inflamed tissue as possible and to maintain high concentrations of antibiotics at the local site [17]. Therefore, we attempted this approach and aimed to report the outcomes of our procedure. Embedding antibiotics in methylmethacrylate cement to enhance therapeutic efficacy at infection sites is a longstanding practice, either as spacers in arthroplasty or during the fixation of arthroplasty components [18,19]. This method includes inserting PMMA antibiotic beads into the joint during surgery and collecting cultures to guide subsequent systemic antibiotic therapy based on these results.
The rationale behind this approach is the advantage of local drug delivery systems that can deliver high concentrations of antibiotics directly to the infection site while maintaining low systemic levels, thereby reducing potential systemic toxicity. This is crucial for achieving therapeutic concentrations in areas with poor blood supply, where the effectiveness of systemic antibiotics may be compromised [20]. Research has addressed concerns regarding chondrotoxicity, especially concerning antibiotics such as vancomycin, noting that concentrations of ≤1 mg/mL did not significantly affect cell proliferation and metabolism [21]. This indicates safe levels for antibiotic-loaded beads. In the current study, beads were prepared by mixing 1,000 mg of vancomycin with 20 g of gentamicin-infused PMMA cement, which is considered within safe limits for preventing chondrotoxic effects [17,22]. This method of using antibiotic-loaded cement beads aims to reduce the high recurrence rates observed with standard arthroscopic treatments. The infection recurrence rate was notably low in this study at 5%. The beads were removed approximately 5 weeks postoperatively to evaluate infection control and the potential for additional procedures, such as synovectomy, as necessary.
The limitations of this study include its retrospective observational design and relatively small sample size, which limit the generalizability of the findings. Additionally, the absence of a control group that was not treated with antibiotic beads makes it difficult to definitively conclude that the combined approach is superior to either arthroscopy or antibiotic beads alone. Furthermore, while the observed recurrence rate was low, the long-term implications compared to standard care over longer follow-up periods remain uncertain.

CONCLUSIONS

A combined arthroscopic debridement and antibiotic-impregnated bead approach for treating septic shoulder arthritis was effective with a very low infection recurrence rate. This method facilitated the direct delivery of antibiotics to infection sites, leading to good patient outcomes. Future research, particularly randomized controlled trials, is needed to confirm the efficacy of this approach. Further studies should also compare both short- and long-term outcomes to standard treatments.

NOTES

Author contributions

Conceptualization: SGP. Data curation: SJP, SGP. Formal analysis: SJP, SGP. Investigation: SGP. Methodology: SGP. Project administration: SJP. Resources: SGP. Software: SGP. Supervision: SGP. Validation: SGP. Visualization: SJP. Writing – original draft: SJP. Writing – review & editing: SJP, SGP. All authors read and agreed to the published version of the manuscript.

Conflict of interest

None.

Funding

None.

Data availability

Contact the corresponding author for data availability.

Acknowledgments

None.

Fig. 1.
(A) Complete assembly of polymethylmethacrylate (PMMA) beads, with each strip composed of seven uniformly-spaced beads arranged in a long, narrow configuration. (B) Arthroscopic image of the shoulder joint after PMMA bead insertion.
cise-2024-00584f1.jpg
Fig. 2.
Diagram of polymethylmethacrylate bead placement in the subacromial space.
cise-2024-00584f2.jpg
Fig. 3.
Postoperative radiograph after arthroscopic synovectomy for septic shoulder arthritis and insertion of antibiotic-impregnated polymethylmethacrylate beads into the subacromial space.
cise-2024-00584f3.jpg
Fig. 4.
Patient no. 9: a 65-year-old female who presented with septic shoulder arthritis. (A) Initial magnetic resonance imaging (MRI) image. (B) Initial arthroscopy findings, where the insertion site of the supraspinatus was observed, but no osteomyelitis was identified. (C) The placement of antibiotic-impregnated beads, completing the surgery. C-reactive protein level subsequently normalized, and clinical symptoms resolved, leading to bead removal. (D) During bead removal, diagnostic arthroscopy showing pus at the supraspinatus insertion site. (E) Additional synovectomy, with bone suspected of osteomyelitis observed and subsequently shaved. (F) The site after the suspected osteomyelitis was removed. (G) Follow-up MRI findings at 1 year, showing no evidence of pyogenic arthritis.
cise-2024-00584f4.jpg
Table 1.
Demographic characteristics and preoperative and postoperative evaluations
Patient no. Sex Age (yr) Medical history
Initial Lab
Operation
Postoperative clinical score
Injection PMHx s/p RCT repair Transferred from LMC WBC (/µL) ESR (mm/hr) CRP (mg/dL) WBC count in joint fluid (/µL) Culture Antibiotics Gächter stage Addition FU (POD, mo) Constant-Murley score DASH score VAS score ASES score
1 F 64 1 - - - 7,140 47 7.17 29,800 MSSA 1st cepha 3 - 13 76 3.4 2 86.66
2 M 52 3 - - - 12,660 43 4.69 87,000 No growth 1st cepha, aminoglycoside 2 - 17 74 12.9 3 74.98
3 M 76 3 HTN, DL - Yes 4,870 47 7.44 24,500 MSSA 1st cepha 3 - 32 47 20.7 3 83.20
4 M 69 - HTN, DM, DL, STEMI - - 8,120 36 23.70 45,600 MSSA 1st cepha 2 - 24 54 28.4 2 66.65
5 F 53 - DL - - 16,080 83 22.84 240,000 Streptococcus pyogenes Vancomycin 2 Knee synovectomy was combined for knee septic arthritis during the 1st operation. 42 69 15.5 5 71.66
6 M 67 3 HTN, angina - - 9,060 29 6.67 104,000 No growth Ciprofloxacin 3 Open exploration d/t hemovac removal site infection 48 79 0 1 95
7 F 74 3 HTN, DM, STEMI - - 9,130 12 16.14 53,900 Streptococcus anginosus Nafcillin 2 - 12 17 87.9 8 15.01
8 F 68 1 HTN, DL - - 14,320 64 1.89 20,000 MSSA 1st cepha, ciprofloxacin 4 - 51 77 2.6 3 85.00
9 F 65 1 - - - 10,180 80 11.75 105,000 MRSA Clindamycin 2 During bead removal, OM was observed in the GT, and curettage was performed. 17 59 26.7 1 71.67
10 F 81 1 - - - 7,500 30 2.62 52,000 No growth 1st cepha 2 RCT repair after bead removal 6 72 26.7 2 81.40
11 M 80 3 - - Yes 13,240 74 11.63 38,000 MSSA 1st cepha 3 - 6 35 62.1 3 49.70
12 F 84 1 HTN - - 8,140 102 6.44 49,600 No growth Ciprofloxacin 4 - 6 73 13.8 1 94.90
13 M 62 1 DM - - 10,170 98 22.43 112,500 MSSA 1st cepha 3 - 62 81 19.7 4 49.00
14 F 78 - Bladder cancer - - 8,370 16 17.47 88,000 No growth 3rd cepha, vancomycin 4 - 15 56 15 0 86.67
15 F 68 - HTN, breast cancer - - 9,940 61 22.69 187,000 No growth Levofloxacin 2 - 12 69 1.7 2 100
16 M 44 - HTN, DM, DL, DM foot - - 11,930 120 15.38 9,200 No growth Levofloxacin 1 - 24 75 6.7 0 94.99
17 M 72 - HTN, liver abscess - - 8,330 16 4.88 2,675 No growth 3rd cepha 2 - 9 68 26.7 1 97.80
18 F 75 2 DL - - 9,090 65 6.13 28,000 No growth 3rd cepha, vancomycin 2 - 6 66 30.6 3 72.64
19 M 62 - - Yes (6 mo ago) Yes 9,790 39 0.73 6,000 Candida parapsilosis Fluconazole 4 Open synovectomy d/t recur 20 36 35.3 2 68.32
20 M 83 - HTN - - 6,500 70 10.08 115,000 No growth 3rd cepha, vancomycin 2 - 6 54 14.8 3 82.85
21 M 62 - HTN, DL Yes (1 yr ago) - 7,960 17 1.14 38,400 No growth Vancomycin 3 - 10 39 48.28 3 30.02
22 F 61 - HTN, RA, DL - - 10,960 12 1.74 35,025 No growth Tigecycline 2 - 6 60 14.7 1 91.20

PMHx: past medical history, s/p: status post, RCT: rotator cuff tear, LMC: local medical center, WBC: white blood cell, ESR: erythrocyte sedimentation rate, CRP: C-reactive protein, FU: follow-up, POD: postoperative day, DASH: disabilities of the arm, shoulder, and hand, VAS: visual analog scale, ASES: American Shoulder and Elbow Surgeons, MSSA: methicillin-sensitive Staphylococcus aureus, Cepha: cephalosporin, HTN: hypertension, DL: dyslipidemia, DM: diabetes mellitus, STEMI: segment elevation myocardial infarction, d/t: due to, MRSA: methicillin-resistant Staphylococcus aureus, OM: osteomyelitis, GT: greater tuberosity, RA: rheumatoid arthritis.

Table 2.
Classification using the Gächter staging system [11]
Stage Description No. (%)
I Opacity of fluid, redness of the synovial membrane, and possible petechiae 1 (5)
II Purulent material, severe inflammation, and fibrinous deposition 11 (50)
III Thickening of the synovial membrane with cartilage erosion 6 (27)
IV Most aggressive stage with subchondral delamination 4 (18)
Table 3.
Demographic data
Variable Value
Total patients 22
Patient characteristics
 Age at surgery (yr) 67.7 (44–84)
 Male sex 11
 Affected shoulder on right side 11
 Cardiovascular diseases 3
 Diabetes mellitus 4
Initial blood test results
 WBC count (cells/µL) 9,703 (4,870–16,080)
 ESR (mm/hr) 52.8 (12–120)
 CRP level (mg/dL) 10.3 (0.73–23.70)
Initial joint fluid analysis
 WBC count (cells/µL) 66,873 (2,675–240,000)

Values are presented as number or median (range).

WBC: white blood cell, ESR: erythrocyte sedimentation rate, CRP: C-reactive protein.

Table 4.
Causative organism on joint fluid culture
Variable No. of patients
No growth 12
Positive culture result 10
Staphylococcus aureus 7
  MSSA 6
  MRSA 1
Streptococcus pyogenes 1
Streptococcus anginosus 1
candida species 1

MSSA: methicillin-sensitive Staphylococcus aureus, MRSA: methicillin-resistant Staphylococcus aureus.

REFERENCES

1. Kaandorp CJ, Dinant HJ, van de Laar MA, Moens HJ, Prins AP, Dijkmans BA. Incidence and sources of native and prosthetic joint infection: a community based prospective survey. Ann Rheum Dis 1997;56:470–5.
crossref pmid pmc
2. Shirtliff ME, Mader JT. Acute septic arthritis. Clin Microbiol Rev 2002;15:527–44.
crossref pmid pmc
3. Goldenberg DL. Septic arthritis. Lancet 1998;351:197–202.
crossref pmid
4. Ivey M, Clark R. Arthroscopic debridement of the knee for septic arthritis. Clin Orthop Relat Res 1985;(199):201–6.
crossref
5. Leslie BM, Harris JM 3rd, Driscoll D. Septic arthritis of the shoulder in adults. J Bone Joint Surg Am 1989;71:1516–22.
crossref pmid
6. Vispo Seara JL, Barthel T, Schmitz H, Eulert J. Arthroscopic treatment of septic joints: prognostic factors. Arch Orthop Trauma Surg 2002;122:204–11.
crossref pmid
7. Jeon IH, Choi CH, Seo JS, Seo KJ, Ko SH, Park JY. Arthroscopic management of septic arthritis of the shoulder joint. J Bone Joint Surg Am 2006;88:1802–6.
crossref pmid
8. Abdel MP, Perry KI, Morrey ME, Steinmann SP, Sperling JW, Cass JR. Arthroscopic management of native shoulder septic arthritis. J Shoulder Elbow Surg 2013;22:418–21.
crossref pmid
9. Kallio MJ, Unkila-Kallio L, Aalto K, Peltola H. Serum C-reactive protein, erythrocyte sedimentation rate and white blood cell count in septic arthritis of children. Pediatr Infect Dis J 1997;16:411–3.
crossref pmid
10. Bierry G, Huang AJ, Chang CY, Torriani M, Bredella MA. MRI findings of treated bacterial septic arthritis. Skeletal Radiol 2012;41:1509–16.
crossref pmid
11. Stutz G, Kuster MS, Kleinstück F, Gächter A. Arthroscopic management of septic arthritis: stages of infection and results. Knee Surg Sports Traumatol Arthrosc 2000;8:270–4.
crossref pmid
12. Joo YB, Lee WY, Shin HD, Kim KC, Kim YK. Risk factors for failure of eradicating infection in a single arthroscopic surgical procedure for septic arthritis of the adult native shoulder with a focus on the volume of irrigation. J Shoulder Elbow Surg 2020;29:497–501.
crossref pmid
13. Ravn C, Neyt J, Benito N, et al. Guideline for management of septic arthritis in native joints (SANJO). J Bone Jt Infect 2023;8:29–37.
crossref pmid pmc
14. Couderc M, Bart G, Coiffier G, et al. 2020 French recommendations on the management of septic arthritis in an adult native joint. Joint Bone Spine 2020;87:538–47.
crossref pmid
15. Korean Society for Chemotherapy; Korean Society of Infectious Diseases; Korean Orthopaedic Association. Clinical guidelines for the antimicrobial treatment of bone and joint infections in Korea. Infect Chemother 2014;46:125–38.
crossref pmc
16. Shim JW, Hong SW, Jeong JY, Lee SM, Yoo JC. Clinical results after arthroscopic treatment of septic shoulder with proximal bone involvement. Indian J Orthop 2020;55(Suppl 1):167–75.
crossref pmid pmc
17. Wang J, Wang L. Novel therapeutic interventions towards improved management of septic arthritis. BMC Musculoskelet Disord 2021;22:530.
crossref pmid pmc
18. van Vugt TA, Arts JJ, Geurts JA. Antibiotic-loaded polymethylmethacrylate beads and spacers in treatment of orthopedic infections and the role of biofilm formation. Front Microbiol 2019;10:1626.
crossref pmid pmc
19. Shahpari O, Mousavian A, Elahpour N, Malahias MA, Ebrahimzadeh MH, Moradi A. The use of antibiotic impregnated cement spacers in the treatment of infected total joint replacement: challenges and achievements. Arch Bone Jt Surg 2020;8:11–20.
crossref pmid pmc
20. Taggart T, Kerry RM, Norman P, Stockley I. The use of vancomycin-impregnated cement beads in the management of infection of prosthetic joints. J Bone Joint Surg Br 2002;84:70–2.
crossref pmid
21. Antoci V Jr, Adams CS, Hickok NJ, Shapiro IM, Parvizi J. Antibiotics for local delivery systems cause skeletal cell toxicity in vitro. Clin Orthop Relat Res 2007;462:200–6.
crossref pmid
22. Klinger HM, Baums MH, Freche S, Nusselt T, Spahn G, Steckel H. Septic arthritis of the shoulder joint: an analysis of management and outcome. Acta Orthop Belg 2010;76:598–603.
pmid
TOOLS
Share :
Facebook Twitter Linked In Google+ Line it
METRICS Graph View
  • 0 Crossref
  •    
  • 238 View
  • 5 Download
Related articles in Clin Should Elbow


ABOUT
ARTICLE CATEGORY

Browse all articles >

BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
#413, 10, Bamgogae-ro 1-gil, Gangnam-gu, Seoul, Republic of Korea
E-mail: journal@cisejournal.org                

Copyright © 2025 by Korean Shoulder and Elbow Society.

Developed in M2PI

Close layer
prev next